Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2...
44 insider purchases on record · latest filing 2026-01-13.
Insiders have also filed 82 sale transactions at CLNN.